申请人:IRONWOOD PHARMACEUTICALS INC
公开号:WO2012009137A1
公开(公告)日:2012-01-19
Modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders are disclosed herein. The compounds are described by structural Formula I:
CRTH2的调节剂,特别是CRTH2的拮抗剂,用于治疗包括哮喘和呼吸系统疾病在内的各种疾病,在这里进行了披露。这些化合物由结构式I描述: